UPDATE 1-US govt aims at high insulin prices with plan for $35 copay in Medicare
The Trump administration on
Wednesday turned back to its pledge to fight high U.S. drug
prices with a plan to limit the out-of-pocket cost for insulin,
a life-saving medicine, to $35 per month for many people with
diabetes who are enrolled in Medicare.
Wednesday turned back to its pledge to fight high U.S. drug
prices with a plan to limit the out-of-pocket cost for insulin,
a life-saving medicine, to $35 per month for many people with
diabetes who are enrolled in Medicare.
Posted by Reuters
